US equities |
MU $1,088.00 ▲+4.06% NVDA $237.47 ▼-0.74% SNDK $1,692.42 ▲+1.92% SPCX $167.60 ▼-2.51% AMD $645.86 ▼-0.55% AAPL $336.67 ▲+0.91% TSLA $377.81 ▼-0.75% META $721.31 ▼-2.38%
FinancialContent

Latest News about NASDAQ:XERS

Recent news which mentions NASDAQ:XERS

XERS Stock Earnings: Xeris Biopharma Holdings Beats EPS, Beats Revenue for Q2 2024
Tickers XERS
Tags Earnings Reports Market News NASDAQ:XERS
From InvestorPlace
XERS Stock Earnings: Xeris Biopharma Holdings Misses EPS, Misses Revenue for Q1 2024
Tickers XERS
Tags XERS NASDAQ:XERS Earnings Reports
From InvestorPlace
XERS Stock Earnings: Xeris Biopharma Holdings Meets EPS, Beats Revenue for Q4 2023
Tickers XERS
Tags Today's Market XERS NASDAQ:XERS
From InvestorPlace
Xeris Biopharma CEO unveils game-changing drug innovations and record financial success
Tags NASDAQ:XERS
From News Direct
Xeris Biopharma CEO unveils record quarterly revenue, underpinned by unique business model
Tags NASDAQ:XERS
From News Direct
Xeris Biopharma CEO reveals impact of CSO's departure and exciting future plans
Tags NASDAQ:XERS
From News Direct
Xeris Biopharma reaches Phase 2 milestone by dosing first participant in hypothyroidism study
Tags NASDAQ:XERS
From News Direct
Xeris Pharmaceuticals shares latest product and partnership updates
Tags NASDAQ:XERS
From News Direct
Xeris Biopharma enters research collaboration with Regeneron Pharmaceuticals to advance XeriJect
Tags NASDAQ:XERS
From News Direct
XERS Stock Pops on Huge FDA News. Here’s What to Know.
Tickers XERS
Tags XERS Market News NASDAQ:XERS
From InvestorPlace